proxy vote
-
SINOVAC Board Wins New York Legal Battle Against Advantech/Prime
SINOVAC Biotech Ltd. successfully defended against a legal challenge in New York, paving the way for its declared $55.00 per share dividend. The court denied Advantech/Prime’s petition, a move that supports the current board’s actions and their plans for further shareholder payouts. Shareholders are encouraged to vote against proposals to oust the current board.
